These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 14383431)

  • 1. [N-methylglucamine antimoniate (glucantime) in therapy of infantile visceral leishmaniasis; a further case of autocthonous infantile visceral leishmaniasis on the island of Elba].
    CAMBI P
    Minerva Dermatol; 1955 Apr; 30(4):126-8. PubMed ID: 14383431
    [No Abstract]   [Full Text] [Related]  

  • 2. [N-methylglucamine antimoniate in the treatment of visceral leishmaniasis; first cases treated in Spain].
    BOIX BARRIOS J
    Rev Cubana Pediatr; 1952 Jul; 24(7):433-42. PubMed ID: 12994219
    [No Abstract]   [Full Text] [Related]  

  • 3. [Case of visceral leishmaniasis in adult treated with N-methylglucamine antimony].
    NAPOLITANO F
    G Med Mil; 1952; 102(6):521-7. PubMed ID: 13034080
    [No Abstract]   [Full Text] [Related]  

  • 4. [Test treatment with N-methylglucamine antimoniate in the diagnosis of kala-azar in children].
    CARVALHO O
    Hospital (Rio J); 1958 Sep; 54(3):387-91. PubMed ID: 13586753
    [No Abstract]   [Full Text] [Related]  

  • 5. [Agranulocytosis caused by glucantime (N-methylglucamine antimoniate) during treatment of kala-azar].
    Gutiérrez Rodero F; Moya Jeromini I; Ortiz de la Tabla Ducasse V; Pozuelo González A
    Med Clin (Barc); 1985 May; 84(20):840. PubMed ID: 4033266
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of visceral leishmaniasis with n-methyl-glucamine antimoniate].
    BOIX BARRIOS J; SANCHO PASQUAU V
    Presse Med (1893); 1951 Nov; 59(71):1475-7. PubMed ID: 14891720
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of American cutaneous leishmaniasis by intra-arterial injections of N-methylglucamine antimoniate].
    Jardim ML; Ferraz G
    Hospital (Rio J); 1965 Sep; 68(3):647-51. PubMed ID: 5295108
    [No Abstract]   [Full Text] [Related]  

  • 8. [Agranulocytosis in visceral leishmaniasis treated with glucantime].
    Bourée P; Dulac O
    Arch Fr Pediatr; 1977; 34(7):659-62. PubMed ID: 931516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of post-kala-azar dermal leishmaniasis with methyl glucamine antimoniate.
    SEN GUPTA PC; BHATTACHARYYA B; DAS AK; SANYAL NN
    J Trop Med Hyg; 1952 Sep; 55(9):205-8. PubMed ID: 13011855
    [No Abstract]   [Full Text] [Related]  

  • 10. Combined liposomal immuno- and chemotherapy of visceral leishmaniasis.
    Everlien H; Hockertz S
    Arzneimittelforschung; 1999 Nov; 49(11):954-61. PubMed ID: 10604050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitivity of Leishmania braziliensis promastigotes to meglumine antimoniate (glucantime) is higher than that of other Leishmania species and correlates with response to therapy in American tegumentary leishmaniasis.
    Azeredo-Coutinho RB; Mendonça SC; Callahan H; Portal AC; Max G
    J Parasitol; 2007 Jun; 93(3):688-93. PubMed ID: 17626365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma.
    Badaro R; Falcoff E; Badaro FS; Carvalho EM; Pedral-Sampaio D; Barral A; Carvalho JS; Barral-Netto M; Brandely M; Silva L
    N Engl J Med; 1990 Jan; 322(1):16-21. PubMed ID: 2104665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effectiveness of therapy inducing contraction of spleen in a rare case of visceral leishmaniasis in adult].
    MAJANI A
    Rass Clin Ter; 1953; 52(4):241-6. PubMed ID: 13145776
    [No Abstract]   [Full Text] [Related]  

  • 14. [Severe forms of visceral infantile leishmaniasis: early salvage treatment by antimonies].
    Pousse H; Radhouane M; Besbes A; Ghedira L; Ben Meriem C; Guediche MN; Hamza A
    Arch Fr Pediatr; 1993 Jan; 50(1):84-5. PubMed ID: 8507148
    [No Abstract]   [Full Text] [Related]  

  • 15. [Note on the use of drugs with antimony base; a case of kala-azar treated with glucantime].
    GIRAUD P; BERNARD R; VINCENT P
    Arch Fr Pediatr; 1954; 11(6):659-62. PubMed ID: 13198287
    [No Abstract]   [Full Text] [Related]  

  • 16. [Transitory acute kidney insufficiency and insulin-dependent after treatment of kala-azar with pentamidine and N-methylglucamine antimony].
    Morin D; Dumas ML; Valette H; Dumas R
    Arch Fr Pediatr; 1991 May; 48(5):349-51. PubMed ID: 1859238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative evaluation of effectiveness of antimony preparations in the treatment of visceral leishmaniasis].
    MIRZOIAN NA
    Med Parazitol (Mosk); 1954; 23(2):161-4. PubMed ID: 13175906
    [No Abstract]   [Full Text] [Related]  

  • 18. Allopurinol in the treatment of American cutaneous leishmaniasis.
    Martinez S; Marr JJ
    N Engl J Med; 1992 Mar; 326(11):741-4. PubMed ID: 1738379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimony containing drug and ECG abnormalities in children with visceral leishmaniasis.
    Zanoni LZ; Brustoloni YM; Melnikov P; Cônsolo CE
    Biol Trace Elem Res; 2009 Dec; 132(1-3):35-40. PubMed ID: 19424667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytogenetic observations after meglumine antimoniate therapy for visceral leishmaniasis.
    Hantson P; Léonard ED; Crutzen-Fayt MC; Léonard A; Vandercam B; Delaere B; Mahieu P
    Pharmacotherapy; 1996; 16(5):869-71. PubMed ID: 8888081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.